ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 76 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $255,000 | +381.1% | 118,675 | +600.9% | 0.01% | +600.0% |
| Q1 2017 | $53,000 | -50.5% | 16,933 | -38.6% | 0.00% | -66.7% |
| Q3 2016 | $107,000 | +87.7% | 27,580 | +29.3% | 0.00% | +200.0% |
| Q2 2016 | $57,000 | -66.1% | 21,337 | -61.0% | 0.00% | -80.0% |
| Q1 2016 | $168,000 | +21.7% | 54,707 | +52.4% | 0.01% | +150.0% |
| Q4 2015 | $138,000 | +213.6% | 35,904 | +148.2% | 0.00% | +100.0% |
| Q3 2015 | $44,000 | -21.4% | 14,463 | +9.2% | 0.00% | 0.0% |
| Q2 2015 | $56,000 | +19.1% | 13,244 | +9.2% | 0.00% | 0.0% |
| Q1 2015 | $47,000 | -53.0% | 12,125 | -18.4% | 0.00% | -50.0% |
| Q4 2014 | $100,000 | -26.5% | 14,856 | +17.7% | 0.00% | 0.0% |
| Q3 2013 | $136,000 | – | 12,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |